logo
Select company
Select metric
$ -180KNet Cash Flow - Investing
VS
Market
71
Sector
50
Industry
36
History
98
$ 9.92Close
$ 4.58 - $ 18.35 52-Week Range
Ticker Information

Ticker

PRTA

Company Name

PROTHENA CORP PUBLIC LTD CO

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROTHENA CORP PUBLIC LTD CO - Net Cash Flow - Investing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PRTA - CF - Investing Historical data
DateNet Cash Flow - Investing
6/30/2025$ -180K
3/31/2025$ -237K
12/31/2024$ -298K
9/30/2024$ -1.77M
6/30/2024$ -2.2M
3/31/2024$ -2.83M
12/31/2023$ -2.77M
9/30/2023$ -1.41M
6/30/2023$ -1.1M
3/31/2023$ -490K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROTHENA CORP PUBLIC LTD CO's latest trailing twelve months (TTM) CF - Investing stands at $ -251K.
  • Over the past 5 years, PROTHENA CORP PUBLIC LTD CO's average CF - Investing has been $ -868.35K.
  • The median CF - Investing for PROTHENA CORP PUBLIC LTD CO during this period was $ -519.5K
  • PROTHENA CORP PUBLIC LTD CO reached its highest CF - Investing over the past 5 years at $ -176K.
  • The lowest CF - Investing recorded by PROTHENA CORP PUBLIC LTD CO in the same timeframe $ -2.83M

PROTHENA CORP PUBLIC LTD CO's CF - Investing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Investing Benchmarks
CompanyCF - Investing
TNXP : TONIX PHARMACEUTICALS HOLDING CORP $ -2.56MCAPR : CAPRICOR THERAPEUTICS INC $ -82.94MLCTX : LINEAGE CELL THERAPEUTICS INC $ 8.41MOCGN : OCUGEN INC $ -710KTVRD : TVARDI THERAPEUTICS INC $ -12.93MABSI : ABSCI CORP $ 27.84MRLAY : RELAY THERAPEUTICS INC $ 20.45MSRZN : SURROZEN INC $ -64KPRME : PRIME MEDICINE INC $ 53.62MVSTM : VERASTEM INC $ 0

Definition of Net Cash Flow - Investing

[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].

PRTA - Net Cash Flow - Investing, Last 5 years

$ -2.83M

Minimum

Mar 31, 2024

$ -176K

Maximum

Jun 30, 2021

$ -868.35K

Average

$ -519.5K

Median

CF - Investing Benchmark Analysis

The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.29M with a standard deviation of $ 83.34M.
The following table provides additional summary stats:
CF - Investing in the Market:
filtered constituents3.17K
min$ -292.23M
max$ 241M
average$ -35.29M
median$ -6.38M
std$ 83.34M